Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts

1 Winters Center for Heart Failure Research, Michael E. DeBakey Department of Veterans Affairs Medical Center, and 3 Thrombosis Section, Baylor College of Medicine and Methodist Hospital, Houston, Texas; 2 Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2005-02, Vol.288 (2), p.H461-H468
Hauptverfasser: Lovelock, Joshua D, Baker, Andrew H, Gao, Feng, Dong, Jing-Fei, Bergeron, Angela L, McPheat, Willie, Sivasubramanian, Natarajan, Mann, Douglas L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page H468
container_issue 2
container_start_page H461
container_title American journal of physiology. Heart and circulatory physiology
container_volume 288
creator Lovelock, Joshua D
Baker, Andrew H
Gao, Feng
Dong, Jing-Fei
Bergeron, Angela L
McPheat, Willie
Sivasubramanian, Natarajan
Mann, Douglas L
description 1 Winters Center for Heart Failure Research, Michael E. DeBakey Department of Veterans Affairs Medical Center, and 3 Thrombosis Section, Baylor College of Medicine and Methodist Hospital, Houston, Texas; 2 Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom; and 4 Molecular Pharmacology Department, AstraZeneca R&D Molndal, AstraZeneca Pharmaceuticals, Gothenburg, Sweden Submitted 29 April 2004 ; accepted in final form 11 August 2004 The balance between matrix metalloproteinases (MMPs) and their natural inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), plays a critical role in cardiac remodeling. Although a number of studies have characterized the pathophysiological role of MMPs in the heart, very little is known with respect to the role of TIMPs in the heart. To delineate the role of TIMPs in the heart we examined the effects of adenovirus-mediated overexpression of TIMP-1, -2, -3, and -4 in cardiac fibroblasts. Infection of cardiac fibroblasts with adenoviral constructs containing human recombinant TIMP (AdTIMP-1, -2, -3, and -4) provoked a significant ( P < 0.0001) 1.3-fold in increase in bromodeoxyuridine (BrdU) incorporation. Similarly, treatment of cardiac fibroblasts with AdTIMP-1-, -2-, -3-, and -4-conditioned medium led to a 1.2-fold increase in BrdU incorporation ( P < 0.0001) that was abolished by pretreatment with anti-TIMP-1, -2, -3, and -4 antibodies. The effects of TIMPs were not mimicked by treating the cells with RS-130830, a broad-based MMP inhibitor, suggesting that the effects of TIMPs were independent of their ability to inhibit MMPs. Infection with AdTIMP-1, -2, -3, and -4 led to a significant increase in -smooth muscle actin staining, consistent with TIMP-induced phenotypic differentiation into myofibroblasts. Finally, infection with AdTIMP-2 resulted in a significant increase in collagen synthesis, whereas infection with AdTIMP-3 resulted in a significant increase in fibroblast apoptosis. TIMPs exert overlapping as well as diverse effects on isolated cardiac fibroblasts. The observation that TIMPs stimulate fibroblast proliferation as well as phenotypic differentiation into myofibroblasts suggests that TIMPs may play an important role in tissue repair in the heart that extends beyond their traditional role as MMP inhibitors. matrix metalloproteinase; proliferation; apoptosis; phenotypic differentiation Address for reprint requests and other correspondence: D. L. Mann, Winters
doi_str_mv 10.1152/ajpheart.00402.2004
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_15650153</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67366170</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-88ad485b188b8fbe62476040bc0fdc861144215a0458136fc158bf04288946763</originalsourceid><addsrcrecordid>eNqFkE9vEzEQxS0EoqHwCZDQnrht8P91uKGqJUiVuJQrltc7zrryxovtFc23x01Ce0KcRpr5vad5D6H3BK8JEfSTuZ9HMKmsMeaYrmkdL9CqXmhLBNu8RCvMJGslYeICvcn5HmMsOsleowsipMAVWqGfWyiQ4g72EJfcgHNgS26ia4rPeYHG70ff-xLTcTmZkvxDM0ExIcQ5xQJ-bzLU476xJg3e2Mb5PsU-mFzyW_TKmZDh3Xleoh8313dX2_b2-9dvV19uW8s3uLRKmYEr0ROleuV6kJR3sqbqLXaDVZIQzikRBnOhCJPOEqF6hzlVasNlzXSJPp5860u_FshFTz5bCMEcc2nZMSlJh_8Lkk0nu452FWQn0KaYcwKn5-Qnkw6aYP3Yv_7bvz72rx_7r6oPZ_uln2B41pwLr8DnEzD63fjbJ9DzeMg-hrg76JslhDt4KE_WNZ-messl0fPgqnj9b_HTO88i9gdnS6nF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19767727</pqid></control><display><type>article</type><title>Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Lovelock, Joshua D ; Baker, Andrew H ; Gao, Feng ; Dong, Jing-Fei ; Bergeron, Angela L ; McPheat, Willie ; Sivasubramanian, Natarajan ; Mann, Douglas L</creator><creatorcontrib>Lovelock, Joshua D ; Baker, Andrew H ; Gao, Feng ; Dong, Jing-Fei ; Bergeron, Angela L ; McPheat, Willie ; Sivasubramanian, Natarajan ; Mann, Douglas L</creatorcontrib><description>1 Winters Center for Heart Failure Research, Michael E. DeBakey Department of Veterans Affairs Medical Center, and 3 Thrombosis Section, Baylor College of Medicine and Methodist Hospital, Houston, Texas; 2 Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom; and 4 Molecular Pharmacology Department, AstraZeneca R&amp;D Molndal, AstraZeneca Pharmaceuticals, Gothenburg, Sweden Submitted 29 April 2004 ; accepted in final form 11 August 2004 The balance between matrix metalloproteinases (MMPs) and their natural inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), plays a critical role in cardiac remodeling. Although a number of studies have characterized the pathophysiological role of MMPs in the heart, very little is known with respect to the role of TIMPs in the heart. To delineate the role of TIMPs in the heart we examined the effects of adenovirus-mediated overexpression of TIMP-1, -2, -3, and -4 in cardiac fibroblasts. Infection of cardiac fibroblasts with adenoviral constructs containing human recombinant TIMP (AdTIMP-1, -2, -3, and -4) provoked a significant ( P &lt; 0.0001) 1.3-fold in increase in bromodeoxyuridine (BrdU) incorporation. Similarly, treatment of cardiac fibroblasts with AdTIMP-1-, -2-, -3-, and -4-conditioned medium led to a 1.2-fold increase in BrdU incorporation ( P &lt; 0.0001) that was abolished by pretreatment with anti-TIMP-1, -2, -3, and -4 antibodies. The effects of TIMPs were not mimicked by treating the cells with RS-130830, a broad-based MMP inhibitor, suggesting that the effects of TIMPs were independent of their ability to inhibit MMPs. Infection with AdTIMP-1, -2, -3, and -4 led to a significant increase in -smooth muscle actin staining, consistent with TIMP-induced phenotypic differentiation into myofibroblasts. Finally, infection with AdTIMP-2 resulted in a significant increase in collagen synthesis, whereas infection with AdTIMP-3 resulted in a significant increase in fibroblast apoptosis. TIMPs exert overlapping as well as diverse effects on isolated cardiac fibroblasts. The observation that TIMPs stimulate fibroblast proliferation as well as phenotypic differentiation into myofibroblasts suggests that TIMPs may play an important role in tissue repair in the heart that extends beyond their traditional role as MMP inhibitors. matrix metalloproteinase; proliferation; apoptosis; phenotypic differentiation Address for reprint requests and other correspondence: D. L. Mann, Winters Center for Heart Failure Research, MS 524, 6565 Fannin, Houston, TX 77030 (E-mail: dmann{at}bcm.tmc.edu )</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.00402.2004</identifier><identifier>PMID: 15650153</identifier><language>eng</language><publisher>United States</publisher><subject>Actins - metabolism ; Adenoviridae - genetics ; Animals ; Apoptosis - physiology ; Cell Division - physiology ; Cells, Cultured ; Culture Media, Conditioned - pharmacology ; Fibroblasts - cytology ; Fibroblasts - metabolism ; Humans ; Mice ; Mice, Inbred C57BL ; Myocardium - cytology ; Myocardium - metabolism ; Recombinant Proteins - antagonists &amp; inhibitors ; Recombinant Proteins - metabolism ; Tissue Inhibitor of Metalloproteinase-1 - antagonists &amp; inhibitors ; Tissue Inhibitor of Metalloproteinase-1 - genetics ; Tissue Inhibitor of Metalloproteinase-1 - metabolism ; Tissue Inhibitor of Metalloproteinase-2 - antagonists &amp; inhibitors ; Tissue Inhibitor of Metalloproteinase-2 - genetics ; Tissue Inhibitor of Metalloproteinase-2 - metabolism ; Tissue Inhibitor of Metalloproteinase-3 - antagonists &amp; inhibitors ; Tissue Inhibitor of Metalloproteinase-3 - genetics ; Tissue Inhibitor of Metalloproteinase-3 - metabolism ; Tissue Inhibitor of Metalloproteinase-4 ; Tissue Inhibitor of Metalloproteinases - antagonists &amp; inhibitors ; Tissue Inhibitor of Metalloproteinases - genetics ; Tissue Inhibitor of Metalloproteinases - metabolism</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2005-02, Vol.288 (2), p.H461-H468</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-88ad485b188b8fbe62476040bc0fdc861144215a0458136fc158bf04288946763</citedby><cites>FETCH-LOGICAL-c490t-88ad485b188b8fbe62476040bc0fdc861144215a0458136fc158bf04288946763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3039,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15650153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lovelock, Joshua D</creatorcontrib><creatorcontrib>Baker, Andrew H</creatorcontrib><creatorcontrib>Gao, Feng</creatorcontrib><creatorcontrib>Dong, Jing-Fei</creatorcontrib><creatorcontrib>Bergeron, Angela L</creatorcontrib><creatorcontrib>McPheat, Willie</creatorcontrib><creatorcontrib>Sivasubramanian, Natarajan</creatorcontrib><creatorcontrib>Mann, Douglas L</creatorcontrib><title>Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol Heart Circ Physiol</addtitle><description>1 Winters Center for Heart Failure Research, Michael E. DeBakey Department of Veterans Affairs Medical Center, and 3 Thrombosis Section, Baylor College of Medicine and Methodist Hospital, Houston, Texas; 2 Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom; and 4 Molecular Pharmacology Department, AstraZeneca R&amp;D Molndal, AstraZeneca Pharmaceuticals, Gothenburg, Sweden Submitted 29 April 2004 ; accepted in final form 11 August 2004 The balance between matrix metalloproteinases (MMPs) and their natural inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), plays a critical role in cardiac remodeling. Although a number of studies have characterized the pathophysiological role of MMPs in the heart, very little is known with respect to the role of TIMPs in the heart. To delineate the role of TIMPs in the heart we examined the effects of adenovirus-mediated overexpression of TIMP-1, -2, -3, and -4 in cardiac fibroblasts. Infection of cardiac fibroblasts with adenoviral constructs containing human recombinant TIMP (AdTIMP-1, -2, -3, and -4) provoked a significant ( P &lt; 0.0001) 1.3-fold in increase in bromodeoxyuridine (BrdU) incorporation. Similarly, treatment of cardiac fibroblasts with AdTIMP-1-, -2-, -3-, and -4-conditioned medium led to a 1.2-fold increase in BrdU incorporation ( P &lt; 0.0001) that was abolished by pretreatment with anti-TIMP-1, -2, -3, and -4 antibodies. The effects of TIMPs were not mimicked by treating the cells with RS-130830, a broad-based MMP inhibitor, suggesting that the effects of TIMPs were independent of their ability to inhibit MMPs. Infection with AdTIMP-1, -2, -3, and -4 led to a significant increase in -smooth muscle actin staining, consistent with TIMP-induced phenotypic differentiation into myofibroblasts. Finally, infection with AdTIMP-2 resulted in a significant increase in collagen synthesis, whereas infection with AdTIMP-3 resulted in a significant increase in fibroblast apoptosis. TIMPs exert overlapping as well as diverse effects on isolated cardiac fibroblasts. The observation that TIMPs stimulate fibroblast proliferation as well as phenotypic differentiation into myofibroblasts suggests that TIMPs may play an important role in tissue repair in the heart that extends beyond their traditional role as MMP inhibitors. matrix metalloproteinase; proliferation; apoptosis; phenotypic differentiation Address for reprint requests and other correspondence: D. L. Mann, Winters Center for Heart Failure Research, MS 524, 6565 Fannin, Houston, TX 77030 (E-mail: dmann{at}bcm.tmc.edu )</description><subject>Actins - metabolism</subject><subject>Adenoviridae - genetics</subject><subject>Animals</subject><subject>Apoptosis - physiology</subject><subject>Cell Division - physiology</subject><subject>Cells, Cultured</subject><subject>Culture Media, Conditioned - pharmacology</subject><subject>Fibroblasts - cytology</subject><subject>Fibroblasts - metabolism</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Myocardium - cytology</subject><subject>Myocardium - metabolism</subject><subject>Recombinant Proteins - antagonists &amp; inhibitors</subject><subject>Recombinant Proteins - metabolism</subject><subject>Tissue Inhibitor of Metalloproteinase-1 - antagonists &amp; inhibitors</subject><subject>Tissue Inhibitor of Metalloproteinase-1 - genetics</subject><subject>Tissue Inhibitor of Metalloproteinase-1 - metabolism</subject><subject>Tissue Inhibitor of Metalloproteinase-2 - antagonists &amp; inhibitors</subject><subject>Tissue Inhibitor of Metalloproteinase-2 - genetics</subject><subject>Tissue Inhibitor of Metalloproteinase-2 - metabolism</subject><subject>Tissue Inhibitor of Metalloproteinase-3 - antagonists &amp; inhibitors</subject><subject>Tissue Inhibitor of Metalloproteinase-3 - genetics</subject><subject>Tissue Inhibitor of Metalloproteinase-3 - metabolism</subject><subject>Tissue Inhibitor of Metalloproteinase-4</subject><subject>Tissue Inhibitor of Metalloproteinases - antagonists &amp; inhibitors</subject><subject>Tissue Inhibitor of Metalloproteinases - genetics</subject><subject>Tissue Inhibitor of Metalloproteinases - metabolism</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE9vEzEQxS0EoqHwCZDQnrht8P91uKGqJUiVuJQrltc7zrryxovtFc23x01Ce0KcRpr5vad5D6H3BK8JEfSTuZ9HMKmsMeaYrmkdL9CqXmhLBNu8RCvMJGslYeICvcn5HmMsOsleowsipMAVWqGfWyiQ4g72EJfcgHNgS26ia4rPeYHG70ff-xLTcTmZkvxDM0ExIcQ5xQJ-bzLU476xJg3e2Mb5PsU-mFzyW_TKmZDh3Xleoh8313dX2_b2-9dvV19uW8s3uLRKmYEr0ROleuV6kJR3sqbqLXaDVZIQzikRBnOhCJPOEqF6hzlVasNlzXSJPp5860u_FshFTz5bCMEcc2nZMSlJh_8Lkk0nu452FWQn0KaYcwKn5-Qnkw6aYP3Yv_7bvz72rx_7r6oPZ_uln2B41pwLr8DnEzD63fjbJ9DzeMg-hrg76JslhDt4KE_WNZ-messl0fPgqnj9b_HTO88i9gdnS6nF</recordid><startdate>20050201</startdate><enddate>20050201</enddate><creator>Lovelock, Joshua D</creator><creator>Baker, Andrew H</creator><creator>Gao, Feng</creator><creator>Dong, Jing-Fei</creator><creator>Bergeron, Angela L</creator><creator>McPheat, Willie</creator><creator>Sivasubramanian, Natarajan</creator><creator>Mann, Douglas L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20050201</creationdate><title>Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts</title><author>Lovelock, Joshua D ; Baker, Andrew H ; Gao, Feng ; Dong, Jing-Fei ; Bergeron, Angela L ; McPheat, Willie ; Sivasubramanian, Natarajan ; Mann, Douglas L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-88ad485b188b8fbe62476040bc0fdc861144215a0458136fc158bf04288946763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Actins - metabolism</topic><topic>Adenoviridae - genetics</topic><topic>Animals</topic><topic>Apoptosis - physiology</topic><topic>Cell Division - physiology</topic><topic>Cells, Cultured</topic><topic>Culture Media, Conditioned - pharmacology</topic><topic>Fibroblasts - cytology</topic><topic>Fibroblasts - metabolism</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Myocardium - cytology</topic><topic>Myocardium - metabolism</topic><topic>Recombinant Proteins - antagonists &amp; inhibitors</topic><topic>Recombinant Proteins - metabolism</topic><topic>Tissue Inhibitor of Metalloproteinase-1 - antagonists &amp; inhibitors</topic><topic>Tissue Inhibitor of Metalloproteinase-1 - genetics</topic><topic>Tissue Inhibitor of Metalloproteinase-1 - metabolism</topic><topic>Tissue Inhibitor of Metalloproteinase-2 - antagonists &amp; inhibitors</topic><topic>Tissue Inhibitor of Metalloproteinase-2 - genetics</topic><topic>Tissue Inhibitor of Metalloproteinase-2 - metabolism</topic><topic>Tissue Inhibitor of Metalloproteinase-3 - antagonists &amp; inhibitors</topic><topic>Tissue Inhibitor of Metalloproteinase-3 - genetics</topic><topic>Tissue Inhibitor of Metalloproteinase-3 - metabolism</topic><topic>Tissue Inhibitor of Metalloproteinase-4</topic><topic>Tissue Inhibitor of Metalloproteinases - antagonists &amp; inhibitors</topic><topic>Tissue Inhibitor of Metalloproteinases - genetics</topic><topic>Tissue Inhibitor of Metalloproteinases - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lovelock, Joshua D</creatorcontrib><creatorcontrib>Baker, Andrew H</creatorcontrib><creatorcontrib>Gao, Feng</creatorcontrib><creatorcontrib>Dong, Jing-Fei</creatorcontrib><creatorcontrib>Bergeron, Angela L</creatorcontrib><creatorcontrib>McPheat, Willie</creatorcontrib><creatorcontrib>Sivasubramanian, Natarajan</creatorcontrib><creatorcontrib>Mann, Douglas L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lovelock, Joshua D</au><au>Baker, Andrew H</au><au>Gao, Feng</au><au>Dong, Jing-Fei</au><au>Bergeron, Angela L</au><au>McPheat, Willie</au><au>Sivasubramanian, Natarajan</au><au>Mann, Douglas L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol Heart Circ Physiol</addtitle><date>2005-02-01</date><risdate>2005</risdate><volume>288</volume><issue>2</issue><spage>H461</spage><epage>H468</epage><pages>H461-H468</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><abstract>1 Winters Center for Heart Failure Research, Michael E. DeBakey Department of Veterans Affairs Medical Center, and 3 Thrombosis Section, Baylor College of Medicine and Methodist Hospital, Houston, Texas; 2 Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom; and 4 Molecular Pharmacology Department, AstraZeneca R&amp;D Molndal, AstraZeneca Pharmaceuticals, Gothenburg, Sweden Submitted 29 April 2004 ; accepted in final form 11 August 2004 The balance between matrix metalloproteinases (MMPs) and their natural inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), plays a critical role in cardiac remodeling. Although a number of studies have characterized the pathophysiological role of MMPs in the heart, very little is known with respect to the role of TIMPs in the heart. To delineate the role of TIMPs in the heart we examined the effects of adenovirus-mediated overexpression of TIMP-1, -2, -3, and -4 in cardiac fibroblasts. Infection of cardiac fibroblasts with adenoviral constructs containing human recombinant TIMP (AdTIMP-1, -2, -3, and -4) provoked a significant ( P &lt; 0.0001) 1.3-fold in increase in bromodeoxyuridine (BrdU) incorporation. Similarly, treatment of cardiac fibroblasts with AdTIMP-1-, -2-, -3-, and -4-conditioned medium led to a 1.2-fold increase in BrdU incorporation ( P &lt; 0.0001) that was abolished by pretreatment with anti-TIMP-1, -2, -3, and -4 antibodies. The effects of TIMPs were not mimicked by treating the cells with RS-130830, a broad-based MMP inhibitor, suggesting that the effects of TIMPs were independent of their ability to inhibit MMPs. Infection with AdTIMP-1, -2, -3, and -4 led to a significant increase in -smooth muscle actin staining, consistent with TIMP-induced phenotypic differentiation into myofibroblasts. Finally, infection with AdTIMP-2 resulted in a significant increase in collagen synthesis, whereas infection with AdTIMP-3 resulted in a significant increase in fibroblast apoptosis. TIMPs exert overlapping as well as diverse effects on isolated cardiac fibroblasts. The observation that TIMPs stimulate fibroblast proliferation as well as phenotypic differentiation into myofibroblasts suggests that TIMPs may play an important role in tissue repair in the heart that extends beyond their traditional role as MMP inhibitors. matrix metalloproteinase; proliferation; apoptosis; phenotypic differentiation Address for reprint requests and other correspondence: D. L. Mann, Winters Center for Heart Failure Research, MS 524, 6565 Fannin, Houston, TX 77030 (E-mail: dmann{at}bcm.tmc.edu )</abstract><cop>United States</cop><pmid>15650153</pmid><doi>10.1152/ajpheart.00402.2004</doi></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 2005-02, Vol.288 (2), p.H461-H468
issn 0363-6135
1522-1539
language eng
recordid cdi_pubmed_primary_15650153
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Actins - metabolism
Adenoviridae - genetics
Animals
Apoptosis - physiology
Cell Division - physiology
Cells, Cultured
Culture Media, Conditioned - pharmacology
Fibroblasts - cytology
Fibroblasts - metabolism
Humans
Mice
Mice, Inbred C57BL
Myocardium - cytology
Myocardium - metabolism
Recombinant Proteins - antagonists & inhibitors
Recombinant Proteins - metabolism
Tissue Inhibitor of Metalloproteinase-1 - antagonists & inhibitors
Tissue Inhibitor of Metalloproteinase-1 - genetics
Tissue Inhibitor of Metalloproteinase-1 - metabolism
Tissue Inhibitor of Metalloproteinase-2 - antagonists & inhibitors
Tissue Inhibitor of Metalloproteinase-2 - genetics
Tissue Inhibitor of Metalloproteinase-2 - metabolism
Tissue Inhibitor of Metalloproteinase-3 - antagonists & inhibitors
Tissue Inhibitor of Metalloproteinase-3 - genetics
Tissue Inhibitor of Metalloproteinase-3 - metabolism
Tissue Inhibitor of Metalloproteinase-4
Tissue Inhibitor of Metalloproteinases - antagonists & inhibitors
Tissue Inhibitor of Metalloproteinases - genetics
Tissue Inhibitor of Metalloproteinases - metabolism
title Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T19%3A27%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heterogeneous%20effects%20of%20tissue%20inhibitors%20of%20matrix%20metalloproteinases%20on%20cardiac%20fibroblasts&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Lovelock,%20Joshua%20D&rft.date=2005-02-01&rft.volume=288&rft.issue=2&rft.spage=H461&rft.epage=H468&rft.pages=H461-H468&rft.issn=0363-6135&rft.eissn=1522-1539&rft_id=info:doi/10.1152/ajpheart.00402.2004&rft_dat=%3Cproquest_pubme%3E67366170%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19767727&rft_id=info:pmid/15650153&rfr_iscdi=true